SSG
BSX icon

Summit Securities Group’s Boston Scientific BSX Stock Holding History

Summit Securities Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$707K – 211
2018
Q4 		$707K Buy
+200
New +$7.25K 0.06% 172

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Securities Group's BSX Position: Q1 2026 in Review

Summit Securities Group increased its Boston Scientific (BSX) stake by 433% in Q1 2026, buying an estimated $763K and bringing the position to 11,744 shares worth $737K. The position accounts for 0.09% of the portfolio, ranked #118.

Summit Securities Group first reported a position in BSX in Q4 2018 and has held it in 10 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Summit Securities Group held 11,744 shares of Boston Scientific worth $737K as of Q1 2026.
  • Summit Securities Group bought 9,542 Boston Scientific shares in Q1 2026, an estimated $763K.
  • Boston Scientific made up 0.09% of Summit Securities Group's portfolio in Q1 2026, its #118 holding.
  • Summit Securities Group first reported a position in Boston Scientific in Q4 2018 and has held it in 10 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.